切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2022, Vol. 16 ›› Issue (02) : 124 -130. doi: 10.3877/cma.j.issn.1674-0785.2022.02.003

临床研究

血清NLRP3、ANGPTL4水平与2型糖尿病下肢动脉病变的关系
赵静1,(), 魏苏1, 李庆凤1, 李伟1   
  1. 1. 234000 安徽宿州,安徽医科大学附属宿州医院内分泌科
  • 收稿日期:2021-08-12 出版日期:2022-02-15
  • 通信作者: 赵静
  • 基金资助:
    安徽省重点研究与开发计划项目(202004j07020026)

Relationship between serum NLRP3 and ANGPTL4 levels and lower extremity arterial disease in type 2 diabetes mellitus

Jing Zhao1,(), Su Wei1, Qingfeng Li1, Wei Li1   

  1. 1. Department of Endocrinology, Suzhou Hospital Affiliated to Anhui Medical University, Suzhou 234000, China
  • Received:2021-08-12 Published:2022-02-15
  • Corresponding author: Jing Zhao
引用本文:

赵静, 魏苏, 李庆凤, 李伟. 血清NLRP3、ANGPTL4水平与2型糖尿病下肢动脉病变的关系[J/OL]. 中华临床医师杂志(电子版), 2022, 16(02): 124-130.

Jing Zhao, Su Wei, Qingfeng Li, Wei Li. Relationship between serum NLRP3 and ANGPTL4 levels and lower extremity arterial disease in type 2 diabetes mellitus[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2022, 16(02): 124-130.

目的

探讨血清核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)、血管生成素样蛋白4(ANGPTL4)与2型糖尿病(T2DM)下肢动脉病变(LEAD)的关系。

方法

选择2019年1月至2021年1月安徽医科大学附属宿州医院内分泌科收治的89例T2DM合并LEAD患者(LEAD组),55例单纯T2DM患者(T2DM组)和50例健康志愿者(健康对照组)。检测血清NLRP3和ANGPTL4水平,收集临床资料,Pearson相关性分析NLRP3、ANGPTL4与静息ABI指数之间相关性。Logistic逐步回归分析NLRP3、ANGPTL4与T2DM合并LEAD的关系。绘制受试者工作特征曲线(ROC)分析NLRP3、ANGPTL4诊断T2DM合并LEAD的价值。

结果

LEAD组血清NLRP3水平高于T2DM组和健康对照组(P<0.05),血清ANGPTL4水平低于T2DM组和健康对照组(P<0.05)。Fontaine's Ⅳ期患者静息踝肱指数(ABI)、ANGPTL4水平低于Ⅲ期和Ⅱa~Ⅱb期患者(P<0.05),NLRP3高于Ⅲ期和Ⅱa~Ⅱb期患者(P<0.05)。NLRP3与静息ABI指数呈负相关(r=-0.893,P<0.05),ANGPTL4与静息ABI指数呈正相关(r=0.805,P<0.05)。T2DM病程≥5年、高胰岛素抵抗指数(HOMA-IR)和高NLRP3是T2DM合并LEAD的危险因素(P<0.05),高ANGPTL4是T2DM合并LEAD的保护因素(P<0.05)。联合NLRP3、ANGPTL4检测诊断T2DM合并LEAD的曲线下面积为0.902,高于单独NLRP3、ANGPTL4的0.698、0.705(P<0.05)。

结论

T2DM合并LEAD患者血清NLRP3水平增高,ANGPTL4降低,且与T2DM合并LEAD的发生以及病情严重程度有关,联合NLRP3和ANGPTL4可为LEAD诊断提供有效信息。

Objective

To investigate the relationship between serum nucleotide binding oligomerization domain-like receptor protein 3 (NLRP3) and angiopoietin-like 4 (ANGPTL4) levels and lower extremity arterial disease (LEAD) in type 2 diabetes mellitus (T2DM).

Methods

From January 2019 to January 2021, 89 T2DM patients with LEAD (LEAD group) treated at the Department of Endocrinology, Suzhou Hospital Affiliated to Anhui Medical University, 55 simple T2DM patients (T2DM group), and 50 healthy volunteers (healthy control group) were selected. Serum NLRP3 and ANGPTL4 levels were detected and clinical data were collected, and the correlation between NLRP3 and ANGPTL4 and resting ankle-brachial index (ABI) was analyzed by Pearson correlation analysis. Logistic regression was used to analyze the relation between NLRP3 and ANGPTL4 and T2DM combined with LEAD. Receiver operating characteristic curve (ROC) was drawn to assess the value of NLRP3 and ANGPTL4 in diagnosing T2DM combined with LEAD.

Results

Serum NLRP3 level in the LEAD group was higher than those in the NLEAD group and healthy control group (P<0.05), and serum ANGPTL4 level was lower than those in the NLEAD group and healthy control group (P<0.05). The levels of resting ABI and ANGPTL4 in Fontaine's stage Ⅳ patients were lower than those in stage Ⅲ and stage Ⅱa~Ⅱb patients (P<0.05), and NLRP3 was higher than that in stage Ⅲ and stage Ⅱa~Ⅱb patients (P<0.05). NLRP3 was negatively correlated with resting ABI (r=-0.893, P<0.05), while ANGPTL4 was positively correlated with resting ABI (r=0.805, P<0.05). T2DM duration ≥5 years, high insulin resistance index, and high NLRP3 were risk factors for T2DM complicated with LEAD (P<0.05), and high ANGPTL4 was a protective factor for T2DM complicated with LEAD (P<0.05). The area under the curve of NLRP3 plus ANGPTL4 was 0.902, which was higher than either of them alone (NLRP3: 0.698; ANGPTL4: 0.705; P<0.05).

Conclusion

Serum NLRP3 level increases and ANGPTL4 level decreases in T2DM patients with LEAD, which is related to the occurrence and severity of T2DM patients with LEAD. The combination of NLRP3 and ANGPTL4 can provide effective information for the diagnosis of LEAD.

表1 3组基线资料以及实验室指标比较
表2 不同Fontaine's分期患者静息ABI指数、NLRP3、ANGPTL4水平差异(
xˉ
±s
图1 NLRP3、ANGPTL4与静息ABI指数散点图注:ABI为静息踝肱指数;NLRP3为核苷酸结合寡聚化结构域样受体蛋白3;ANGPTL4为血管生成素样蛋白4
表3 T2DM合并LEAD的多因素Logistic回归分析
表4 NLRP3、ANGPTL4诊断T2DM合并LEAD的效能分析
图2 NLRP3、ANGPTL4诊断T2DM合并LEAD的ROC曲线注:NLRP3为核苷酸结合寡聚化结构域样受体蛋白3;ANGPTL4为血管生成素样蛋白4;T2DM为2型糖尿病;LEAD为下肢动脉病变
1
Buso G, Aboyans V, Mazzolai L. Lower extremity artery disease in patients with type 2 diabetes [J]. Eur J Prev Cardiol, 2019, 26(2 suppl): 114-124.
2
韩孟冉, 敖娜, 王鹤, 等. 单核细胞/高密度脂蛋白比值与2型糖尿病患者下肢动脉粥样硬化性疾病的相关性分析 [J]. 中国全科医学, 2021, 24(6): 663-668.
3
Grebe A, Hoss F, Latz E. NLRP3 inflammasome and the IL-1 pathway in atherosclerosis [J]. Circ Res, 2018, 122(12): 1722-1740.
4
杨茜, 陈红. ANGPTL4与糖脂代谢及动脉粥样硬化相关疾病的研究进展 [J]. 医学综述, 2018, 24(9): 1693-1697.
5
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版) [J]. 中华糖尿病杂志, 2018, 10(1): 4-67.
6
Becker F. Exploration of arterial function with noninvasive technics. Results in chronic arterial occlusive disease of the lower limbs according to Leriche and Fontaine classification [J]. Int Angiol, 1985, 4(3): 311-322.
7
Buso G, Collet TH, Wojtusciszyn A, et al. Should patients with type 2 diabetes be screened for lower extremity arterial disease? [J]. Rev Med Suisse, 2019, 15(674): 2236-2240.
8
Groh L, Keating ST, Joosten LAB, et al. Monocyte and macrophage immunometabolism in atherosclerosis [J]. Semin Immunopathol, 2018, 40(2): 203-214.
9
Gao L, Dong Q, Song Z, et al. NLRP3 inflammasome: a promising target in ischemic stroke [J]. Inflamm Res, 2017, 66(1): 17-24.
10
Ding S, Xu S, Ma Y, et al. Modulatory mechanisms of the NLRP3 inflammasomes in diabetes [J]. Biomolecules, 2019, 9(12): 850.
11
Ferreira NS, Bruder-Nascimento T, Pereira CA, et al. NLRP3 inflammasome and mineralocorticoid receptors are associated with vascular dysfunction in type 2 diabetes mellitus [J]. Cells, 2019, 8(12): 1595.
12
Hoseini Z, Sepahvand F, Rashidi B, et al. NLRP3 inflammasome: its regulation and involvement in atherosclerosis [J]. J Cell Physiol, 2018, 233(3): 2116-2132.
13
He Y, Zeng MY, Yang D, et al. NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux [J]. Nature, 2016, 530(7590): 354-357.
14
Cai H, Wang P, Zhang B, et al. Expression of the NEK7/NLRP3 inflammasome pathway in patients with diabetic lower extremity arterial disease [J]. BMJ Open Diabetes Res Care, 2020, 8(2): e001808.
15
Aryal B, Price NL, Suarez Y, et al. ANGPTL4 in metabolic and cardiovascular disease [J]. Trends Mol Med, 2019, 25(8): 723-734.
16
Cho DI, Kang HJ, Jeon JH, et al. Antiinflammatory activity of ANGPTL4 facilitates macrophage polarization to induce cardiac repair [J]. JCI Insight, 2019, 4(16): e125437.
17
He XW, Shen YG, Zhu M, et al. Angiopoietin-like protein 4 serum levels and gene polymorphisms are associated with large artery atherosclerotic stroke [J]. J Neurol Sci, 2016, 362: 333-338.
18
Aryal B, Rotllan N, Araldi E, et al. ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progression [J]. Nat Commun, 2016, 7: 12313.
19
Ding S, Wu D, Lu Q, et al. Angiopoietin-like 4 deficiency upregulates macrophage function through the dysregulation of cell-intrinsic fatty acid metabolism [J]. Am J Cancer Res, 2020, 10(2): 595-609.
20
Lan G, Xie W, Li L, et al. MicroRNA-134 actives lipoprotein lipase-mediated lipid accumulation and inflammatory response by targeting angiopoietin-like 4 in THP-1 macrophages [J]. Biochem Biophys Res Commun, 2016, 472(3): 410-417.
21
侯贺翔, 李利, 姚克纯, 等. 超声对Ⅱ型糖尿病下肢动脉病变相关测量的新指标 [J]. 中国超声医学杂志, 2017, 33(5): 459-462.
22
王君玓, 商广芸. 2型糖尿病患者下肢动脉粥样硬化病变与血糖水平的相关性 [J]. 山东医药, 2018, 58(14): 45-47.
23
梁越, 张慧文, 郑月宏. 老年下肢动脉粥样硬化危险因素分析 [J]. 中华老年多器官疾病杂志, 2018, 17(8): 561-564.
[1] 曹雯佳, 刘学兵, 罗安果, 钟释敏, 邓岚, 王玉琳, 李赵欢. 超声矢量血流成像对2型糖尿病患者颈动脉壁剪切应力的研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(07): 709-717.
[2] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[3] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[4] 刘盾, 潘晟. 不同入路腹腔镜袖状胃切除术用于肥胖症合并2型糖尿病的效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 150-154.
[5] 赵帅, 王伟, 李瑞奇, 周家杰, 王道荣. 3D腹腔镜下袖状胃切除术治疗肥胖合并2型糖尿病的临床疗效及影响因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 146-149.
[6] 陆文琪, 赵艳茹, 李焕娣, 樊欣娜, 王佳, 李萍. 2型糖尿病患者血清SMAD2和SOX6表达及其与蛋白尿的关系[J/OL]. 中华肾病研究电子杂志, 2024, 13(03): 145-151.
[7] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[8] 王璇, 娜扎开提·尼加提, 雒洋洋, 蒋升. 皮肤晚期糖基化终末产物浓度与2型糖尿病微血管并发症的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 447-454.
[9] 孙秀芹, 高美娟, 张琼阁, 吕凯敏, 王宏宇. 京西地区无心血管病史2型糖尿病中老年人群患心血管疾病的危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(03): 245-252.
[10] 孙琳, 韩萍萍, 张碧琳, 张军霞. 血清WISP1水平与2型糖尿病患者血尿酸升高的相关性[J/OL]. 中华临床医师杂志(电子版), 2024, 18(02): 178-182.
[11] 吴晓明, 翟仰魁, 王娟, 张硕, 许杰, 潘从清. 男性2 型糖尿病患者空腹C 肽和定量胰岛素敏感性检测指数与血浆致动脉粥样硬化指数的相关性[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(04): 288-294.
[12] 张梅, 陈卉, 李转霞, 王瑞, 李林娟. Metrnl和NLRP3炎症小体:糖尿病肾病的潜在诊断标志物[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 193-199.
[13] 吴子龙, 吴冰, 袁开盛, 胡瑞翔, 杨华, 王存川. 肥胖与胰腺疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 213-219.
[14] 崔磊, 徐东升. 减重手术治疗肥胖患者胰岛素抵抗的研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 127-132.
[15] 赵稳, 刘浩, 李丁昌, 高文星, 刘先强, 武现生, 董光龙. 重视SADI-S手术全流程质量控制[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(01): 15-20.
阅读次数
全文


摘要